{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:44:43Z","timestamp":1792759483353,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012082.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000}}],"reference-count":106,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012082.pub3","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:34:46Z","timestamp":1790246086000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews"],"prefix":"10.1002","volume":"2026","author":[{"given":"Alvin M","family":"Katumba","sequence":"additional","affiliation":[{"name":"Radcliffe Department of Medicine; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Dor\u00e9e","sequence":"additional","affiliation":[{"name":"Radcliffe Department of Medicine; University of Oxford; Oxford UK"},{"name":"Systematic Review Initiative; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4309-9162","authenticated-orcid":false,"given":"Lise J","family":"Estcourt","sequence":"additional","affiliation":[{"name":"Radcliffe Department of Medicine; University of Oxford; Oxford UK"},{"name":"Systematic Review Initiative; Oxford UK"},{"name":"Haematology\/Transfusion Medicine; NHS Blood and Transplant; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"7526","key":"10.1002\/14651858.CD012082.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"issue":"16","key":"10.1002\/14651858.CD012082.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"9757","key":"10.1002\/14651858.CD012082.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"9861","key":"10.1002\/14651858.CD012082.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2012","journal-title":"Lancet"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012082.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1182\/blood-2023-189287","article-title":"Estimating sickle cell disease prevalence by state: a model using US-born and foreign-born state-specific population data","volume":"142","author":"Fu","year":"2023","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0006|cit6","unstructured":"National Haemoglobinopathy Registry NHR \u2013 Home 2026"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Thomson","year":"2023","journal-title":"Lancet Haematology"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e100516","DOI":"10.1371\/journal.pone.0100516","article-title":"The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival","volume":"9","author":"Rumaney","year":"2014","journal-title":"PLOS ONE"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"American Journal of Hematology"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ajh.20642","article-title":"Cerebrovascular disease associated with sickle cell pulmonary hypertension","volume":"81","author":"Kato","year":"2006","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0015|cit15","unstructured":"US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute Expert Panel Report 2014 Evidence-based management of sickle cell disease: Expert Panel Report, 2014 http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/asheducation-2013.1.439","article-title":"Transfusion therapy for sickle cell disease: a balancing act","volume":"2013","author":"Chou","year":"2013","journal-title":"Hematology"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson","year":"2007","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0022|cit22","first-page":"447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"1","author":"Porter","year":"2013","journal-title":"ASH Education Program Book"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3181c70e14","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"339","author":"Scheunemann","year":"2010","journal-title":"American Journal of the Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2141-9248.105655","article-title":"Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria","volume":"2","author":"Ubesie","year":"2012","journal-title":"Annals of Medical and Health Sciences Research"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/asheducation-2006.1.48","article-title":"Red cell exchange in sickle cell disease","volume":"2006","author":"Swerdlow","year":"2006","journal-title":"Hematology"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5664\/jcsm.26805","article-title":"A patient with sickle cell disease and a low baseline sleeping oxygen saturation","volume":"3","author":"Wagner","year":"2007","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1537-2995.1987.27387235626.x","article-title":"Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion","volume":"27","author":"Schmalzer","year":"1987","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimes in the perioperative management of sickle cell disease","volume":"333","author":"Vichinsky","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub3-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003146.pub4","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","author":"Estcourt","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007843.pub2","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","author":"Alhashimi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub3-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008360.pub5","article-title":"Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease","author":"Estcourt","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub3-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003149.pub4","article-title":"Preoperative blood transfusions for sickle cell disease","author":"Estcourt","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0033|cit33","unstructured":"Pollock M Fernandes RM Becker LA Pieper D Hartling L Chapter V: Overviews of reviews (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Cochrane Handbook for Systematic Reviews of Interventions 2024"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0034|cit34","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"issue":"11","key":"10.1002\/14651858.CD012082.pub3-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010820.pub2","article-title":"Interventions for improving upper limb function after stroke","author":"Pollock","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012389.pub3","article-title":"Interventions for preventing silent cerebral infarcts in people with sickle cell disease","author":"Estcourt","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012082.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202.pub3","article-title":"Hydroxyurea (hydroxycarbamide) for sickle cell disease","author":"Rankine-Mullings","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Shea BJ Grimshaw JM Wells GA Boers M Andersson N Hamel C Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews BMC Medical Research Methodology 2007 7 10","DOI":"10.1186\/1471-2288-7-10"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jclinepi.2014.12.009","article-title":"Systematic review found AMSTAR, but not R(evised)-AMSTAR to have good measurement properties","volume":"68","author":"Pieper","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE Guidelines 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated October 2019). Cochrane, 2024 Available from handbook.cochrane.org","DOI":"10.1002\/9781119536604.ch8"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N et al; on behalf of the Cochrane GRADEing Methods Group (formerly Applicability and Recommendations Methods Group) and the Cochrane Statistical Methods Group Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated October 2019). Cochrane, 2024 Available from handbook.cochrane.org","DOI":"10.1002\/9781119536604.ch14"},{"issue":"07","key":"10.1002\/14651858.CD012082.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012943.pub2","article-title":"Interventions for treating neuropathic pain in people with sickle cell disease","author":"Asnani","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub3-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011633.pub3","article-title":"Treatment of dental complications in sickle cell disease","author":"Mulimani","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"06","key":"10.1002\/14651858.CD012082.pub3-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011752","article-title":"Interventions for treating pulmonary hypertension in people with sickle cell disease or thalassaemia","author":"Bowers","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012082.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012187.pub2","article-title":"Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults","author":"CooperIan","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"04","key":"10.1002\/14651858.CD012082.pub3-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003350.pub3","article-title":"Pain management for sickle cell disease in children and adults","author":"Dunlop","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"08","key":"10.1002\/14651858.CD012082.pub3-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012082.pub2","article-title":"Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews","author":"Fortin","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub3-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006111.pub2","article-title":"Piracetam for reducing the incidence of painful sickle cell disease crises","author":"Al Hajeri","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub3-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002042.pub4","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","author":"Carson","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004222.pub2","article-title":"Treatment for women with postpartum iron deficiency anaemia","author":"Dodd","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub3-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003426.pub4","article-title":"Drugs for preventing red blood cell dehydration in people with sickle cell disease","author":"Nagalla","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005406.pub4","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","author":"Okomo","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010155.pub2","article-title":"Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease","author":"Zuuren","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202","article-title":"Hydroxyurea for sickle cell disease","author":"Jones","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003733.pub3","article-title":"Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease","author":"Knight-Madden","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012082.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005598.pub3","article-title":"Antibiotics for treating community acquired pneumonia in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001475","article-title":"Blood transfusion for treating malarial anaemia","author":"Meremikwu","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006110.pub4","article-title":"Antibiotics for treating acute chest syndrome in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004198.pub4","article-title":"Treatments for priapism in boys and men with sickle cell disease","author":"Chinegwundoh","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007843.pub4","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","author":"Dolatkhah","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008394.pub4","article-title":"Interventions for treating leg ulcers in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010985.pub4","article-title":"Interventions for treating intrahepatic cholestasis in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub3-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004344.pub7","article-title":"Treatment for avascular necrosis of bone in people with sickle cell disease","author":"Mart\u00ed-Carvajal","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010378.pub3","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","author":"Okusanya","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012082.pub3-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004448.pub7","article-title":"Phytomedicines (medicines derived from plants) for sickle cell disease","author":"Oniyangi","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012082.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007001.pub5","article-title":"Hematopoietic stem cell transplantation for people with sickle cell disease","author":"Oringanje","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012082.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003425.pub4","article-title":"Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease","author":"Owusu-Ofori","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub3-BIB0070|cit70","article-title":"Interventions for chronic kidney disease in people with sickle cell disease","author":"Roy","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012082.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007652.pub7","article-title":"Gene therapy for sickle cell disease","author":"Olowoyeye","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006786.pub2","article-title":"Interventions for treating painful sickle cell crisis during pregnancy","author":"Mart\u00ed-Carvajal","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0073|cit73","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"26","key":"10.1002\/14651858.CD012082.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD012082.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"issue":"10019","key":"10.1002\/14651858.CD012082.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012082.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"e2013062","DOI":"10.4084\/mjhid.2013.062","article-title":"Sickle cell disease: management options and challenges in developing countries","volume":"5","author":"Ansong","year":"2013","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jrsm.1229","article-title":"Risk of bias in overviews of reviews: a scoping review of methodological guidance and four-item checklist","volume":"8","author":"Ballard","year":"2017","journal-title":"Research Synthesis Methods"},{"issue":"2","key":"10.1002\/14651858.CD012082.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Advances"},{"issue":"8","key":"10.1002\/14651858.CD012082.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0081|cit81","first-page":"164","article-title":"Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia","volume":"28","author":"Al-Jaouni","year":"2006","journal-title":"Bahrain Medical Bulletin"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1447\u201352","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease","volume":"319","author":"Koshy","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2141.2012.09105.x","article-title":"Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)","volume":"157","author":"Styles","year":"2012","journal-title":"British Journal of Haematology"},{"issue":"9778","key":"10.1002\/14651858.CD012082.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2141.2010.08523.x","article-title":"The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial","volume":"152","author":"Wang","year":"2011","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/03630269.2012.697948","article-title":"Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease","volume":"36","author":"Jain","year":"2012","journal-title":"Hemoglobin"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"2585\u201393","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use of hydroxyurea in an African region with malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1099\u2013105","DOI":"10.1002\/ajh.24198","article-title":"Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: a phase III international randomized clinical trial","volume":"90","author":"Hankins","year":"2015","journal-title":"American Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9343(98)00056-4","article-title":"A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia","volume":"104","author":"Foucan","year":"1998","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0093|cit93","first-page":"11013","article-title":"Effect of lisinopril on microalbuminuria in sickle cell anaemia children: a single-blind randomized controlled trial","volume":"8","author":"Aliu","year":"2020","journal-title":"International Journal of Pediatrics-Mashhad"},{"issue":"8467","key":"10.1002\/14651858.CD012082.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2164\/jandrol.110.010934","article-title":"A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial - the priapism in sickle cell study","volume":"32","author":"Olujohungbe","year":"2011","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0035-9203(87)90049-6","article-title":"Topical antibiotics in chronic sickle cell leg ulcers","volume":"81","author":"Baum","year":"1987","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0098|cit98","first-page":"121","article-title":"A randomized controlled trial of solcoseryl and duoderm in chronic sickle cell ulcers","volume":"42","author":"La Grenade","year":"1993","journal-title":"West Indian Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD012082.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2010.08395.x","article-title":"A randomized phase II trial of arginine butyrate with standard local therapy in refractory sickle cell leg ulcers","volume":"151","author":"McMahon","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD012082.pub3-BIB0100|cit100","first-page":"164","article-title":"Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration","volume":"26","author":"Serjeant","year":"1977","journal-title":"West Indian Medical Journal"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0190-9622(18)30758-8","article-title":"Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study","volume":"37","author":"Serjeant","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD012082.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1182\/blood.V84.6.1775.1775","article-title":"Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group","volume":"84","author":"Wethers","year":"1994","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD012082.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2106\/00004623-200612000-00003","article-title":"Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment","volume":"88","author":"Neumayr","year":"2006","journal-title":"Journal of Bone and Joint Surgery"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0104|cit104","first-page":"200","article-title":"Clinical evaluation of extract of Cajanuscajan (Ciklavit) in sickle cell anaemia","volume":"51","author":"Akinsulie","year":"2005","journal-title":"Journal of Tropical Paediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012082.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1078\/0944-7113-00040","article-title":"Double-blind, placebo controlled,randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder","volume":"8","author":"Wambebe","year":"2001","journal-title":"Phytomedicine"},{"key":"10.1002\/14651858.CD012082.pub3-BIB0106|cit106","first-page":"386","article-title":"Pfaffia paniculata extract improves hydration of eritrocytes in vitro and sickle cell disease symptoms","volume":"66","author":"Araujo","year":"2009","journal-title":"Revista Brasileira de Medicina"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:05:45Z","timestamp":1792757145000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012082.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":106,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012082.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}